E-Cigarettes vaping regulation in the US

October 15, 2022 0 Comments

E-Cigarettes vaping regulation in the US
The United States government has increasingly adopted and supported policies and regulations aimed at regulating e-cigarettes vaping in the interest of safeguarding the health of the Americans. E-cigarettes entail the users using devices that contain nicotine that is heated to vapour and then inhaled and exhaled. E-cigarettes take the exhaling and inhaling of the nicotine vapour as opposed to the normal cigarette smoking that involves smoke. The E-cigarettes have health harmful effects that affect the American prompting the government to adopt regulatory measures to discourage the production of the product as well as its consumption across the U.S. Equally important, the e-cigarettes devices contain liquid contains nicotine, favouring and other additives that are harmful to the body. E-cigarettes is addictive and thus the e-cigarettes are classified under the tobacco products that are similarly regulated by the government and its agencies. E-cigarettes contain other harmful such as the ultrafine particles that can be inhaled in the lungs, flavouring chemicals such as diacetyl that are connected to lung diseases, volatile organic compounds, heavy metals such as lead, tin and nickel that are harmful to the body. The ingredients found in the e-cigarette causes insignificant and unavoidable health risks to people across the Us. his regard, the e-cigarettes results to harmful adverse effects of damaging the body, issues of addiction, damaging of the brain and can result to cancers such as cancer 0of the lungs. The government has taken the initiative through legislation to control the use of e-cigarette vamping to ensure that the health of its people is safeguarded. On the other hand, people end up losing lives and money in the treatment of e-cigarette related health effects and the government spend a considerable amount of taxpayers’ money to ensure that the harmful effects of e-cigarettes are countered. The e-cigarette vamping have negative impacts on social, financial, cultural and the economic life of the people and the government and the government has taken the initiative to regulate the consumption of the product through government agencies such as FDA, CTP, Juul Stats, medical platforms.
FDA regulation of e-cigarette vamping
The Food and Drug Administration (FDA) has engaged in the regulation and the control of the e-cigarettes by restricting the consumption of the product by a section of people in the society and evaluating the products used in the manufacture of the product. The regulation of the e-cigarette under the FDA is done by the Center for Tobacco Products (CTP) (Gostin, Lawrence and Aliza, 2014). The CPT has the authority and powers to control the roll-your-own tobacco, smokeless tobacco, cigarette tobacco through the Tobacco Control Act o0f 2009. The control and regulation of e-cigarette vaping are done through different approaches, policies and strategies. First, the regulation of e-cigarettes is done on the young generation those below the age of 18. The sale of e-cigarettes to persons below the age of 18 is restricted and the young people are prohibited from the consumption of the products (Mackey, Miner and Cuomo, 2015). Under the same, the persons purchasing the products have to undergo age verification and photo identity card. The rule bans the distribu8tion of free samples and the sale of the cigarette products using the vending machines unless in the cases they are located in adult facilities. The fact that young people are not introduced to e-cigarette at a young age ensures that the government can reduce their chance of ever using cigarette products thus reducing the impacts of the harmful impacts brought by the product. This approach and policies ensure that people under the age of 18 do not access e-cigarette as they are prohibited and the venders are prevented from availing the products to the young people.
The FDA has increasingly conducted manufacturer and retailer checks to ensure that they adhere to the regulation policies, regulation and strategies to control the distribution of e-cigarette products. The inspection is conducted on the Electronic Nicotine Delivery System (ENDS) and vape shops to make and modify the ENDS products (Pepper, Ribisl and Brewer, 2016). The CPT has continuously inspected to ensure that the retailers and the manufacturers adhere to the Federal Food, Drug, and Cosmetic Act and other FDA regulations. Additionally, the CTP ensures the manufacturers and the retailers are not engaged in the commercial marketing of tobacco products without seeking the appropriate premarket authorization from the various bodies and agencies. Organizations and companies involved in the violation of the regulation and control policies labelling, advertising, and selling e-cigarettes without proper authorizations are given warnings and other stern legal actions taken against them (Kaisar et al., 2016). Therefore, the regulation of the manufacturers and retailers ensures that e-products are sold to the right person and that the businesses do not violate the regulations.
The CTP has increased the requirements of the END manufacturers in the process of regulating the e-cigarettes. In 2009, the CPT engaged in the regulation of the ENDS from the legal and regulatory that had been in the existences before its formation (Dantonio, 2013). The regulation became applicable to the e-cigarettes and other cigarette products to ensure that effective control measures are put in place. In the course of regulation the CTP has introduced additional regulatory and requirements such as registration of establishments, submitting of products together with their advertisement and labels for evaluation, the submission of tobacco health documents, submitting tobacco health ingredients, , submitting ingredients list and including appropriate warning statements for effective regulation of the of the product consumption. The measures ensure that the END manufacturers engage the market fairly and adhere to set rules.
Medical regulation of E-cigarettes vaping
E-cigarette vaping have negative impacts on the people’s health and thus medical bodies/organizations and medical professionals have engaged in the regulation of the products. Different medical institutions such as Centre for Disease Control, and Prevention (CDC) have researched E-cigarette harmful effects and published such researches to create awareness among the people (Barrington, Samet and McConnell, 2014). The researches indicate the ingredients of cigarettes and their corresponding health impacts, long term impacts of consumption and use of the product and other vital information that the public should know about the e-cigarettes. The reports are available to the members of the public and the government and arte thus used in making regulatory policies and legislation to control and regulate the consumption of e-cigarettes and other related products. Therefore, the reports and research given by medical organization are used as regulatory measures as they caution the public from consuming the products and guides the government in making and evaluating the polices on the product consumption.
The medical organizations have informed the decision of the CTP and FDA regarding the waning and caution clauses to be contai9ned in the e-cigarettes and other related products. The medical organization evaluates and lists the products that are contained in the e-cigarette and their impacts (Rigotti, 2018). This message is vital in the creation and development of the warning signs on the product. For instance, CDC notes that regular cigarettes have warning signs but the e-cigarette lacks the warning signs despite the product having similar health harmful impact on the health of the consumer. In this case, the medical organization argues that warning messages and clauses need to be contained in the e-cigarettes just as in the case of regular cigarettes. The medical organization decides on the messages that should be contained on the packaging of every product concerning their respective harmful effects on the health. Therefore, health organizations play a vital role in cautioning the users of e-cigarettes that regulating the consumption of the product.
Additionally, medical organizations have adopted campaigns against the consumption of the products together with agencies and organizations such as the FDA. The medical have relevant information to caution people against the consumption of e-cigarettes (Palazzolo, 2013). The research enables them to back their campaign with hard facts that effectively ensure the consumers reduce or stop the consumption of such products. The medical professionals have increasingly contributed to the campaigns by advising the FDA on the steps to be taken and key areas of the campaign. For instance, in 2018 the FDA together with medical organizations and medical professionals engaged in a campaign targeted at adolescent to caution them on the use of e-cigarettes by using images of worm-like creatures that were crawling under the skin, brain, and lungs as a result of e-cigarettes consumption. The campaigns from medical organizations and bodies have been effective regulation against the consumption of e-cigarette vaping.
Juul Stats regulation
Juul stat products were found to contain high levels of nicotine as compared to other regular cigarettes and that a considerable population had been engaged in its consumption. The disturbing issue was that a high number of children and people below the age of 18 were engaged in the use of the Juul. In this regard, there is a need for regulation to ensure effective regulation was made to control the consumption of the product. First, the regulation on Juul was done by eliminating illegal advertisement messages that claimed that the product was less harmful than tobacco cigarettes. The advertisement violated the FDA requirements. The Juul was presented with warning letters from the FDA as their misleading statement led to the youths consuming the harmful product. Consequently, the FDA called for the complete ban of the product. This approach ensured that the product would be faced out of the markets.
Recommendation and Conclusion
The regulation of E-cigarettes has received substantial achievements as a result of combined efforts by different parties and authorities to counter the sale and consumption of the harmful product. The government realizes the short and long-term harmful impacts of e-cigarettes vamping and thus the continued effort to end the vice. In this case, the government uses different agencies such as the FDA, CPT and medical organization and professions to counter the vice. The different parties have policies, legal requirements and regulation that are consistently implemented in the elimination of e-cigarettes and other similar harmful products in the market. To effectively control the e-cigarettes and other related harmful products the government need to empower the FDA, CPT and other related medical organizations to effectively implement their purpose, the e-cigarette users need to be continuously rehabilitated, create awareness among the public and in the public institution such as schools on the harmful effects of the e-cigarettes, stern legal measures need to be taken against retailer, manufactures or any other parties involved in the violation of the set rules and regulations by the FDA. Therefore, the implementation of all the policies and regulation and recommendations will significantly reduce the consumption of e-cigarettes.

Barrington-Trimis, J. L., Samet, J. M., & McConnell, R. (2014). Flavorings in electronic cigarettes: an unrecognized respiratory health hazard?. Jama, 312(23), 2493-2494.
Dantonio, N. (2013). Vape Away: Why A Minimalist Regulatory Structure Is the Best Option for FDA E-Cigarette Regulation. U. Rich. L. Rev., 48, 1319.
Gostin, L. O., & Glasner, A. Y. (2014). E-cigarettes, vaping, and youth. Jama, 312(6), 595-596.
Kaisar, M. A., Prasad, S., Liles, T., & Cucullo, L. (2016). A decade of e-cigarettes: limited research & unresolved safety concerns. Toxicology, 365, 67-75.
Mackey, T. K., Miner, A., & Cuomo, R. E. (2015). Exploring the e-cigarette e-commerce marketplace: identifying Internet e-cigarette marketing characteristics and regulatory gaps. Drug and alcohol dependence, 156, 97-103.
Palazzolo, D. L. (2013). Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review. Frontiers in public health, 1, 56.
Pepper, J. K., Ribisl, K. M., & Brewer, N. T. (2016). Adolescents’ interest in trying flavoured e-cigarettes. Tobacco control, 25(Suppl 2), ii62-ii66.
Rigotti, N. A. (2018). Balancing the benefits and harms of e-cigarettes: a national academies of science, engineering, and medicine report. Annals of internal medicine, 168(9), 666-667.